Abstract
Purpose To report population pharmacokinetic (PK) analysis of the phase 1 study (FPA144-001, NCT02318329) and to select a clinical dose and schedule t......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
